Scott Chan

Scott Chan moved from China to the U.S. with family at the age of ten. He passed the rigorous entrance exam and attended the merit-based Stuyvesant High School, widely held to be best public school in New York City. He earned undergraduate degrees from New York University followed by an MBA degree from the Zicklin School of Business at Baruch College.

Shortly thereafter Scott partnered with Dr. Stephen Leeb on numerous financial publications. Today, he serves as the lead analyst for Real World Investing and The Complete Investor.

Mr. Chan is an avid baseball fan and enjoys outdoor activities in his spare time. A multicultural person, he reads Chinese and speaks fluent Mandarin and Cantonese Chinese.

Analyst Articles

Sell Jazz Pharmaceuticals (NASDAQ: JAZZ).  As you know, Brain Trust Profits (BRAIN) has merged with Profit Catalyst Alert (PCA), managed by Linda McDonough.  PCA has sold JAZZ today.  The stock price had risen above Brain Trust Profits’ suggested buy-up-to price of $160 and was a… Read More

Buy to open the iShares 20+ Year Treasury Bond ETF (NASDAQ: TLT) September 21, 2018 $118 call option. Pay no more than $2.40. My bond indicator is bullish enough to warrant buying a call on the Treasury Bond ETF. For those following my 3-Pot system, this is a Pot-1 trade. Read More

On Friday morning, we sold four stocks: AAR Corporation (NYSE: AIR), ChannelAdvisor (NYSE: ECOM), AngioDynamics (NASDAQ: ANGO) and Sotheby’s (NYSE: BID). All four stocks have exceeded our suggested buy-up-to price. Amidst the higher market volatility, we decided to take the gains. AAR Corp. has been a consistent performer for us… Read More

Sell AAR Corporation (NYSE: AIR), AngioDynamics (NASDAQ: ANGO). ChannelAdvisor (NYSE: ECOM) and Sotheby’s (NYSE: BID). We recommend taking gains on AIR, ANGO, ECOM, and BID. More details to come in today’s weekly update later. Read More